US BANCORP \DE\ - CLEVELAND BIOLABS INC ownership

Quarter-by-quarter ownership
US BANCORP \DE\ ownership history of CLEVELAND BIOLABS INC
ValueSharesWeighting
Q2 2021$5,0000.0%1,0000.0%0.00%
Q1 2021$5,0001,000
+900.0%
0.00%
Q3 2018$01000.0%0.00%
Q2 2018$01000.0%0.00%
Q1 2018$01000.0%0.00%
Q4 2017$01000.0%0.00%
Q3 2017$01000.0%0.00%
Q2 2017$01000.0%0.00%
Q1 2017$01000.0%0.00%
Q4 2016$01000.0%0.00%
Q3 2016$01000.0%0.00%
Q2 2016$01000.0%0.00%
Q1 2016$01000.0%0.00%
Q4 2015$01000.0%0.00%
Q3 2015$01000.0%0.00%
Q2 2015$01000.0%0.00%
Q1 2015$01000.00%
Other shareholders
CLEVELAND BIOLABS INC shareholders Q3 2021
NameSharesValueWeighting ↓
THOMPSON DAVIS & CO., INC. 1,800$8,0000.01%
VANGUARD GROUP INC 4,644,077$162,991,0000.01%
LADENBURG THALMANN FINANCIAL SERVICES INC. 38,888$158,0000.00%
Winfield Associates, Inc. 786$3,0000.00%
Virtu KCG Holdings LLC 11,022$48,0000.00%
UBS Group AG 182$00.00%
BLACKROCK ADVISORS LLC 2,800$12,0000.00%
US BANCORP \DE\ 100$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 37$00.00%
BANK OF AMERICA CORP /DE/ 150$1,0000.00%
View complete list of CLEVELAND BIOLABS INC shareholders